IL105475A - PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS

Info

Publication number
IL105475A
IL105475A IL105475A IL10547593A IL105475A IL 105475 A IL105475 A IL 105475A IL 105475 A IL105475 A IL 105475A IL 10547593 A IL10547593 A IL 10547593A IL 105475 A IL105475 A IL 105475A
Authority
IL
Israel
Prior art keywords
dehydro
dihydroxy
vitamin
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL105475A
Other languages
English (en)
Other versions
IL105475A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL105475A0 publication Critical patent/IL105475A0/xx
Publication of IL105475A publication Critical patent/IL105475A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL105475A 1992-04-24 1993-04-21 PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS IL105475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87337492A 1992-04-24 1992-04-24

Publications (2)

Publication Number Publication Date
IL105475A0 IL105475A0 (en) 1993-08-18
IL105475A true IL105475A (en) 1997-06-10

Family

ID=25361517

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105475A IL105475A (en) 1992-04-24 1993-04-21 PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS

Country Status (10)

Country Link
US (1) US5395830A (de)
EP (1) EP0567352B1 (de)
JP (1) JP2769960B2 (de)
KR (1) KR940005275A (de)
AT (1) ATE135220T1 (de)
AU (1) AU666529B2 (de)
CA (1) CA2094424C (de)
DE (1) DE69301750T2 (de)
IL (1) IL105475A (de)
NZ (1) NZ247406A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
KR100474517B1 (ko) * 1997-10-27 2005-07-21 삼성전자주식회사 엘씨디패널절단장치
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
WO2001022934A2 (en) * 1999-09-24 2001-04-05 Yng Wong Quing Non Delivery of small doses of ingestible treatments
US7888338B2 (en) * 2004-12-06 2011-02-15 K.U. Leuven Research & Development 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes
CN101400263B (zh) 2006-03-10 2012-10-03 帝斯曼知识产权资产管理有限公司 苯甲酸或其衍生物在制造营养药物组合物中的用途
CA2981549A1 (en) * 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN106265695B (zh) 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4255596A (en) * 1980-02-25 1981-03-10 Gulf Research & Development Company Preparation of ethylene glycol from ethylene
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4822609A (en) * 1984-12-21 1989-04-18 The Procter & Gamble Company Treatment of osteoporosis
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA2010982C (en) * 1989-02-28 2000-06-13 Toshio Matsumoto Osteogenesis promotion with use of vitamin d derivatives

Also Published As

Publication number Publication date
ATE135220T1 (de) 1996-03-15
NZ247406A (en) 1999-05-28
JP2769960B2 (ja) 1998-06-25
KR940005275A (ko) 1994-03-21
DE69301750T2 (de) 1996-07-25
DE69301750D1 (de) 1996-04-18
AU666529B2 (en) 1996-02-15
IL105475A0 (en) 1993-08-18
CA2094424A1 (en) 1993-10-25
US5395830A (en) 1995-03-07
EP0567352A1 (de) 1993-10-27
AU3689193A (en) 1993-10-28
JPH0624992A (ja) 1994-02-01
EP0567352B1 (de) 1996-03-13
CA2094424C (en) 2001-01-02

Similar Documents

Publication Publication Date Title
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
AU2711295A (en) Combination treatment for inhibiting bone loss
WO1994027589A3 (en) Antidepressant dosage form
GB9410987D0 (en) High dosage pharmaceutical compositions
AU2553992A (en) Bone-growth-stimulating composition
PL303937A1 (en) Application of an antiestrogen compound and pharmaceutical agent
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
UA41355C2 (uk) Засіб для лікування нейро-сніду
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
CA2135710A1 (en) Melatonin derivatives for use in treating desynchronization disorders
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
IL105474A0 (en) Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis
AU1188492A (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
EP0618812A4 (de) Verwendung von protease nexin-i als mittel gegen entzündungen.
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
CA2136140A1 (en) Carcinostatic for hormonotherapy containing dienogest as effective component
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force